| Primary |
| Hypothyroidism |
66.7% |
| Thyroidectomy |
6.7% |
| Hypertension |
5.6% |
| Autoimmune Thyroiditis |
4.4% |
| Basedow's Disease |
3.3% |
| Generalised Resistance To Thyroid Hormone |
2.2% |
| Goitre |
2.2% |
| Type 2 Diabetes Mellitus |
2.2% |
| Blood Thyroid Stimulating Hormone Decreased |
1.1% |
| Diabetes Mellitus |
1.1% |
| Endocrine Ophthalmopathy |
1.1% |
| Hormone Replacement Therapy |
1.1% |
| Post Procedural Hypothyroidism |
1.1% |
| Urinary Tract Infection |
1.1% |
|
| Completed Suicide |
15.5% |
| Respiratory Arrest |
10.3% |
| Weight Increased |
10.3% |
| Atrial Fibrillation |
5.2% |
| Heart Rate Increased |
5.2% |
| Overdose |
5.2% |
| Pharmaceutical Product Complaint |
5.2% |
| Swelling |
5.2% |
| Blood Pressure Increased |
3.4% |
| Cardiac Arrest |
3.4% |
| Cardio-respiratory Arrest |
3.4% |
| Hepatic Steatosis |
3.4% |
| Medication Error |
3.4% |
| Multiple Drug Overdose Intentional |
3.4% |
| Palpitations |
3.4% |
| Product Quality Issue |
3.4% |
| Rash |
3.4% |
| Thyroxine Increased |
3.4% |
| Abortion Spontaneous |
1.7% |
| Acute Myocardial Infarction |
1.7% |
|
| Secondary |
| Hypothyroidism |
36.8% |
| Product Used For Unknown Indication |
24.0% |
| Coronary Artery Disease |
6.8% |
| Ill-defined Disorder |
6.1% |
| Thyroid Disorder |
5.4% |
| Autoimmune Thyroiditis |
3.7% |
| Multiple Sclerosis |
3.4% |
| Demyelination |
2.0% |
| Tri-iodothyronine Decreased |
2.0% |
| Maternal Exposure Timing Unspecified |
1.4% |
| Thyroidectomy |
1.4% |
| Bipolar Disorder |
1.0% |
| Chronic Obstructive Pulmonary Disease |
1.0% |
| Hypertension |
1.0% |
| Osteoporosis |
1.0% |
| Anxiety |
0.7% |
| Basedow's Disease |
0.7% |
| Drug Use For Unknown Indication |
0.7% |
| Glaucoma |
0.7% |
| Cardiac Failure Congestive |
0.3% |
|
| Weight Increased |
20.0% |
| Hypothyroidism |
12.9% |
| Blood Potassium Increased |
5.7% |
| Blood Pressure Increased |
5.7% |
| Colon Cancer |
5.7% |
| Drug Ineffective |
5.7% |
| Hepatic Steatosis |
5.7% |
| Weight Fluctuation |
5.7% |
| Chest Pain |
2.9% |
| Cough |
2.9% |
| Drug Hypersensitivity |
2.9% |
| Myocardial Ischaemia |
2.9% |
| Palpitations |
2.9% |
| Product Quality Issue |
2.9% |
| Rheumatoid Arthritis |
2.9% |
| Swelling Face |
2.9% |
| Unevaluable Event |
2.9% |
| Urinary Tract Infection |
2.9% |
| Urticaria |
2.9% |
| Abortion Spontaneous |
1.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
22.7% |
| Drug Use For Unknown Indication |
16.4% |
| Hypertension |
7.3% |
| Hypothyroidism |
6.9% |
| Pain |
5.9% |
| Osteoporosis |
5.1% |
| Depression |
4.9% |
| Hormone Replacement Therapy |
3.6% |
| Thyroid Disorder |
3.6% |
| Rheumatoid Arthritis |
3.2% |
| Diabetes Mellitus |
2.9% |
| Multiple Myeloma |
2.5% |
| Gastrooesophageal Reflux Disease |
2.2% |
| Blood Cholesterol Increased |
2.1% |
| Fistulogram |
2.0% |
| Breast Cancer |
2.0% |
| Nuclear Magnetic Resonance Imaging |
2.0% |
| Arthritis |
1.7% |
| Anxiety |
1.6% |
| Asthma |
1.5% |
|
| Weight Decreased |
11.3% |
| Vomiting |
9.1% |
| Death |
7.4% |
| Weight Increased |
6.7% |
| Nausea |
5.2% |
| Pain |
5.2% |
| Pneumonia |
4.8% |
| Rash |
4.8% |
| Wrong Technique In Drug Usage Process |
4.6% |
| Drug Ineffective |
4.4% |
| Insomnia |
4.1% |
| Somnolence |
4.1% |
| Vision Blurred |
4.1% |
| Breast Cancer |
3.9% |
| Thrombocytopenia |
3.7% |
| Breast Cancer Female |
3.5% |
| Fatigue |
3.5% |
| Oedema Peripheral |
3.5% |
| Pruritus |
3.1% |
| Urinary Tract Infection |
3.1% |
|
| Interacting |
| Product Used For Unknown Indication |
37.9% |
| Drug Use For Unknown Indication |
10.3% |
| Hypothyroidism |
10.3% |
| Atrial Fibrillation |
6.9% |
| Depression |
6.9% |
| Hypercholesterolaemia |
6.9% |
| Hypertension |
6.9% |
| Hyperlipidaemia |
3.4% |
| Hypocalcaemia |
3.4% |
| Ill-defined Disorder |
3.4% |
| Renal Transplant |
3.4% |
|
| Hypothyroidism |
40.0% |
| Drug Interaction |
20.0% |
| Transient Global Amnesia |
20.0% |
| Palpitations |
10.0% |
| Weight Increased |
10.0% |
|
